BioPharmX Corp·4

Apr 19, 5:46 PM ET

BioPharmX Corp 4

4 · BioPharmX Corp · Filed Apr 19, 2017

Insider Transaction Report

Form 4
Period: 2017-04-18
Transactions
  • Award

    Option to purchase common stock

    2017-04-18$0.74/sh+200,000$148,000200,000 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)
    Exercise: $0.74From: 2017-05-18Exp: 2027-04-18Common stock (200,000 underlying)
Footnotes (2)
  • [F1]This option vests ratably over 12 months with the first vesting starting on 5/18/17.
  • [F2]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT